Tevogen Bio
TVGN
Performance
About Tevogen Bio
Tevogen Bio is a late-stage biotechnology company specializing in immunotherapy using cytotoxic T lymphocytes. Its ExacTcell platform enables scalable, off-the-shelf allogeneic CTLs for the treatment of cancers, viral infections, and prevention of long-term complications, with applications spanning oncology, neurology, and virology. The company focuses on making personalized T cell therapeutics more affordable and accessible, and is headquartered in New Jersey, United States. Tevogen also explores AI-assisted approaches through Tevogen.AI to accelerate product development while aligning pricing with broad patient access.
Recent News
No recent news for this company.
Recent Deals
No recent deals for this company.